PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Human Cell1 citations

Chebulagic acid targets FBXO38 to enhance natural killer cell-mediated anti-tumor immunity in lung adenocarcinoma

View Full Paper
XHXiaozhou HuRSRui ShaLZLei Zhang

Key Points

  • Chebulagic acid enhances natural killer cell-mediated anti-tumor immunity in lung adenocarcinoma.
  • The expression of FBXO38 is a significant factor in this immune response.
  • Assessment of immune markers demonstrates improved efficacy against tumors when treated with chebulagic acid.
  • Further clinical research is warranted to evaluate the therapeutic potential of chebulagic acid in cancer treatment.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hu et al. (2026) studied this question.

synapsesocial.com/papers/69a759f9c6e9836116a1f695https://doi.org/10.1007/s13577-026-01347-7
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future2023 · 102 citations
  2. 2Norketamine, the Main Metabolite of Ketamine, Induces Mitochondria-Dependent and ER Stress-Triggered Apoptotic Death in Urothelial Cells via a Ca2+-Regulated ERK1/2-Activating Pathway2022 · 13 citations
  3. 3Targeting FAK, VEGF, and MTA1 proteins with Terminalia elliptica: a computational approach for anticancer activity2024 · 2 citations
  4. 4Abstract 4879: Determination of chebulagic acid and chebulinic acid and their pharmacokinetics in mouse .2013 · 4 citations
  5. 5FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells2018 · 312 citations